Talecris Biotherapeutics Holdings Corp. (NASDAQ:TLCR)

CAPS Rating: No stars

Results 1 - 4 of 4

Recs

0
Member Avatar jimgggg1 (< 20) Submitted: 10/28/2010 11:09:59 AM : Outperform Start Price: $24.34 TLCR Score: -40.92

They have been sold. $29.42 is the value of deal last Friday. That anyone is still selling for under $25 is just crazy.

Recs

0
Member Avatar BadCopNoDonuts (< 20) Submitted: 9/21/2010 10:29:13 AM : Outperform Start Price: $22.90 TLCR Score: -38.92

Following Deej in Caps, but I sure wouldn't buy any in R.L. after seeing how many shares insiders have dumped in the last month!

Recs

0
Member Avatar pennstrock (< 20) Submitted: 10/23/2009 11:06:58 PM : Underperform Start Price: $19.59 TLCR Score: +27.17

Cerberus needs money for the folly of investing in Chrysler. The money from the IPO has all gone to them. Nothing was left for TLCr to run their operations; so they will be tight on cash for a while. The investors already took out th money thy inevested and a billion more! I'd stay away from this stock.

Recs

0
Member Avatar bebam5 (< 20) Submitted: 10/20/2009 2:29:59 PM : Underperform Start Price: $19.50 TLCR Score: +24.89

thsi stock is like a utility, with matuer products and limited pipeline, with significant risk of lower reimbursement under health reform measures proposed. Although insured patient pool may rise, the reimbursements must go down, and if the patent period is shortened they will lose valuable end-of-cycle revenue to service the debt.

Results 1 - 4 of 4

Featured Broker Partners


Advertisement